These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12507251)

  • 1. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations.
    Chisolm JJ
    J Toxicol Clin Toxicol; 2000; 38(4):365-75. PubMed ID: 10930052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
    Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C
    J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meso-2,3-dimercaptosuccinic acid in the treatment of occupationally exposed lead workers.
    Restek-Samarzija N; Blanusa M; Pizent A; Samarzija M; Turk R; Corović N; Jurasović J
    Arh Hig Rada Toksikol; 1998 Jun; 49(2):137-45. PubMed ID: 9919719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
    Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
    J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral treatment of avian lead intoxication with meso-2,3-dimercaptosuccinic acid.
    Hoogesteijn AL; Raphael BL; Calle P; Cook R; Kollias G
    J Zoo Wildl Med; 2003 Mar; 34(1):82-7. PubMed ID: 12723805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rash and pyrexia after succimer (dimercaptosuccinic acid; DMSA).
    Varma A; Bradberry SM; Vale JA
    Clin Toxicol (Phila); 2017 Aug; 55(7):680. PubMed ID: 28349748
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of heme metabolites following chelation therapy with meso 2,3-dimercaptosuccinic acid (DMSA).
    Tutunji MF; al-Mahasneh QM
    J Toxicol Clin Toxicol; 1994; 32(3):267-76. PubMed ID: 8007034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
    Glotzer DE
    Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
    Graziano JH; Siris ES; LoIacono N; Silverberg SJ; Turgeon L
    Clin Pharmacol Ther; 1985 Apr; 37(4):431-8. PubMed ID: 2983924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB; Anderson RL; Super DM
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.
    Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI
    PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of different lead biomarkers in their associations with lead-related symptoms.
    Lee BK; Ahn KD; Lee SS; Lee GS; Kim YB; Schwartz BS
    Int Arch Occup Environ Health; 2000 Jul; 73(5):298-304. PubMed ID: 10963412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.